V38M (p.Val38Met) variant of KRT6A (Keratin, type II cytoskeletal 6A)

V38M (p.Val38Met) in KRT6A (Keratin, type II cytoskeletal 6A) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.30 / 1. The record also includes population frequency data and structural context.

V38M (p.Val38Met) variant details